We present the case of a women diagnosed with Wegener's disease at the age of 26 years, refractory to corticosteroid and cyclophosphamide therapy. Treatment with intravenous immunoglobulin (IVIg) was started, leading to partial clinical remission of disease. During IVIg treatment she became pregnant. IVIg therapy was continued, the disease went into remission, and after 40 weeks the patient delivered a healthy boy. After 6 months from the delivery, the patient became pregnant again. Now she is at the 22nd week of pregnancy and she is doing very well. This case supports the beneficial effect of IVIg in Wegener's granulomatosis and illustrates its safety and efficacy during pregnancy.

Bellisai, F., Morozzi, G., Marcolongo, R., & Galeazzi, M. (2004). Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin. CLINICAL RHEUMATOLOGY, 23(6), 533-535 [10.1007/s10067-004-0932-5].

Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin

BELLISAI, FRANCESCA;MOROZZI, GABRIELLA;GALEAZZI, MAURO
2004

Abstract

We present the case of a women diagnosed with Wegener's disease at the age of 26 years, refractory to corticosteroid and cyclophosphamide therapy. Treatment with intravenous immunoglobulin (IVIg) was started, leading to partial clinical remission of disease. During IVIg treatment she became pregnant. IVIg therapy was continued, the disease went into remission, and after 40 weeks the patient delivered a healthy boy. After 6 months from the delivery, the patient became pregnant again. Now she is at the 22nd week of pregnancy and she is doing very well. This case supports the beneficial effect of IVIg in Wegener's granulomatosis and illustrates its safety and efficacy during pregnancy.
Bellisai, F., Morozzi, G., Marcolongo, R., & Galeazzi, M. (2004). Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin. CLINICAL RHEUMATOLOGY, 23(6), 533-535 [10.1007/s10067-004-0932-5].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/6741
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo